Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function.
Kostense S, Ogg GS, Manting EH, Gillespie G, Joling J, Vandenberghe K, Veenhof EZ, van Baarle D, Jurriaans S, Klein MR, Miedema F. Kostense S, et al. Among authors: van baarle d. Eur J Immunol. 2001 Mar;31(3):677-86. doi: 10.1002/1521-4141(200103)31:3<677::aid-immu677>3.0.co;2-m. Eur J Immunol. 2001. PMID: 11241270 Free article.
Dysfunctional Epstein-Barr virus (EBV)-specific CD8(+) T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma.
van Baarle D, Hovenkamp E, Callan MF, Wolthers KC, Kostense S, Tan LC, Niesters HG, Osterhaus AD, McMichael AJ, van Oers MH, Miedema F. van Baarle D, et al. Among authors: van oers mh. Blood. 2001 Jul 1;98(1):146-55. doi: 10.1182/blood.v98.1.146. Blood. 2001. PMID: 11418474 Free article.
Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells.
Kostense S, Otto SA, Knol GJ, Manting EH, Nanlohy NM, Jansen C, Lange JM, van Oers MH, Miedema F, van Baarle D. Kostense S, et al. Among authors: van oers mh, van baarle d. Eur J Immunol. 2002 Apr;32(4):1080-9. doi: 10.1002/1521-4141(200204)32:4<1080::AID-IMMU1080>3.0.CO;2-R. Eur J Immunol. 2002. PMID: 11920575 Free article.
Spontaneous outgrowth of EBV-transformed B-cells reflects EBV-specific immunity in vivo; a useful tool in the follow-up of EBV-driven immunoproliferative disorders in allograft recipients.
Vossen MT, Gent MR, Davin JC, Baars PA, Wertheim-van Dillen PM, Weel JF, Roos MT, van Baarle D, Groothoff J, van Lier RA, Kuijpers TW. Vossen MT, et al. Among authors: van lier ra, van baarle d. Transpl Int. 2004 Feb;17(2):89-96. doi: 10.1007/s00147-003-0665-4. Epub 2003 Dec 2. Transpl Int. 2004. PMID: 14652716 Free article.
234 results